ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
about
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeSociety of Gynecologic Oncology recommendations for the prevention of ovarian cancerHereditary and familial colon cancerGenetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineGastrointestinal tract cancers: Genetics, heritability and germ line mutationsPatient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice.Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto RicoUsing genetics and genomics strategies to personalize therapy for cancer: focus on melanomaDuctal carcinoma in situ in a 25-year-old man presenting with apparent unilateral gynecomastiaContralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern BrazilGenomic era diagnosis and management of hereditary and sporadic colon cancer.Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer.Considerations and management of a patient with three metachronous cancers in association with Lynch syndrome and ileal Crohn's disease: A case report.Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriersEfficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.Metastasis of Pregnancy-Associated Breast Cancer (Suspected to Be Hereditary Breast and Ovarian Cancer) to the Brain, Diagnosed at 18 Weeks' Gestation: A Case Report and Review of the Literature.Hereditary diffuse gastric cancer: prophylactic surgical oncology implicationsManagement options after prophylactic surgeries in women with BRCA mutations: a review.Genetic counseling for DAPK1 mutation in a chronic lymphocytic leukemia familyScoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.Physicians' experiences with BRCA1/2 testing in community settingsAmerican Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancerDesmoid tumor of the supraclavicular region: a case reportTargeting lymphotoxin-mediated negative selection to prevent prostate cancer in mice with genetic predisposition.Extracolonic manifestations of hereditary colorectal cancer syndromes.Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use.Aggressive fibromatosis of the larynx: case report and brief review.Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes.Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome).Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.Hereditary thyroid cancer syndromes and genetic testing.Colorectal polyposis: clinical presentation and surgical treatment.Desmoid Tumor of the Pancreas: Case Report and Review of a Rare Entity.Engagement with Genetic Information and Uptake of Genetic Testing: the Role of Trust and Personal Cancer History.Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.
P2860
Q24655053-D3AA48BD-C220-48E9-BF3E-DC2E7D14DCFBQ27009306-C4B8DC33-D6ED-4F9C-813F-D1C46465CE95Q28280647-ADD9377B-5DE2-43C9-B647-3D07060612F6Q30513982-E3A6F1AB-152F-4453-B0FB-7DC9DA5A852BQ33599436-9E4786E0-3809-4CFE-88F3-4D2C59E834A1Q33780087-CF829735-FFD8-4ED0-9FD1-E0FB07353331Q33862772-435F5FF3-1360-4AA2-BC92-4CD7C67E6E94Q33965328-F3283C19-E177-4229-9593-140F36EB366DQ34035454-E84B296C-881E-4BD8-A5FF-9B0E6842793BQ34358066-2528161C-8085-4DCC-8102-57F4AD9895E7Q34562565-8402EE61-739D-4BB0-8B4F-F48ED4296DFDQ34657586-D83201B9-582A-45AF-ACF9-320AE5136F42Q35219159-1398C790-5ACF-41F3-A20F-1A5637DB2685Q35601625-0F6F3114-64C2-47AC-8DAB-F29C2F36E1B3Q35782790-2EACAFCE-55E1-4526-97B5-444668D7FA87Q35994562-09D1DFD3-3E17-4E27-917A-BCC6A1C4C0D3Q36101775-B505A90C-5FA4-4BEB-B7BC-D59B40B54A21Q36615358-439E8876-47DB-4063-A73F-F1EBEEA13BBCQ36923864-3B36CA54-0024-4EF4-A671-F4ABF419518FQ36959824-0AC2133B-6456-413C-A61C-A366E8A4981DQ37016147-4E9D883D-FA35-4909-AC55-347C10019E29Q37083675-88E6E4ED-B80A-4726-A8A8-683616C8EDEDQ37103116-859AFAEF-598D-45AB-8F4A-7D37FB633979Q37157589-72DDEA7B-7A8F-46F2-AD70-DD320DFB602BQ37230423-F45E3CB3-F9DD-42AC-9D6B-62FCFC40683DQ37338569-365254C4-91B0-4C60-A5C2-E04D289A8A37Q37385949-0B158533-637E-435A-A9A6-17A7A58ABB29Q37427872-1C6DE974-E57F-4E1B-A46E-C5223A6E0B7FQ37629639-0CE4AFA5-8481-4A35-9B85-0D504B2A3D3FQ37746657-8F448E93-82BF-4C99-BDAC-20B85AF54CE9Q37889423-5C8FDFBD-E0F7-4C44-B4FD-581740B1CF10Q38089260-B06C147F-3EFD-4AAA-A63E-5FAB7952027DQ38090971-1070B75E-9B28-4F74-A376-9FA00915A8AEQ38241489-B877BB0A-0526-4C1A-8796-9F8473FCF66AQ38263389-40CB59C9-CA9A-48C6-8CEB-E6450B0F7A05Q38289723-FA5E495C-DA80-4BE8-A059-134F6CFB428FQ38555230-D6C3F253-6EF8-4E2E-8EBC-4A5436B3DC4BQ39010918-E14BD86F-3ABD-4998-84A6-CF76418F5D90Q39402487-5D1D8C9D-848C-4873-8127-BF07A66D295AQ42616545-6BF73455-91A9-4E76-A698-A184E2B594D9
P2860
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
ASCO/SSO review of current rol ...... n hereditary cancer syndromes.
@en
ASCO/SSO review of current rol ...... n hereditary cancer syndromes.
@nl
type
label
ASCO/SSO review of current rol ...... n hereditary cancer syndromes.
@en
ASCO/SSO review of current rol ...... n hereditary cancer syndromes.
@nl
prefLabel
ASCO/SSO review of current rol ...... n hereditary cancer syndromes.
@en
ASCO/SSO review of current rol ...... n hereditary cancer syndromes.
@nl
P2093
P50
P356
P1476
ASCO/SSO review of current rol ...... n hereditary cancer syndromes.
@en
P2093
Andrew Berchuck
Barbara L Weber
Beth Y Karlan
David G Mutch
Francis Giardiello
James Church
Jeffrey F Moley
José G Guillem
Miguel A Rodriguez-Bigas
P304
P356
10.1200/JCO.2005.04.5260
P407
P577
2006-10-01T00:00:00Z